Genital Diseases, Female  >>  cisplatin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

32 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cisplatin / Generic mfg.
NCT00003358: Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Completed
1
24
US
chemotherapy, cisplatin, gemcitabine hydrochloride
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
01/01
 
NCT00320983: Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer

Completed
1
11
US
Topotecan, Hycamtin, Cisplatin, Platinol AQ
University of New Mexico
Cervical Cancer
06/04
12/05
NCT00251888: CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto

Completed
1
15
Europe
campto (irinotecan), cisplatin (cisplatyl)
ARCAGY/ GINECO GROUP
Cervix Cancer
 
11/05
NCT00002913: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer

Completed
1
30
US
paclitaxel, Anzatax, Asotax, TAX, Taxol, cisplatin, CACP, CDDP, CPDD, DDP, topotecan hydrochloride, hycamptamine, Hycamtin, SKF S-104864-A, TOPO, filgrastim, G-CSF, Neupogen
National Cancer Institute (NCI)
Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
07/07
 
NCT00068549: Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer

Completed
1
13
US
Gemcitabine Hydrochloride, dFdC, dFdCyd, Cisplatin, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, Irradiation, RT, Internal Radiation Therapy, Brachytherapy, Internal Radiation, Internal Radiation Brachytherapy, Radiation Brachytherapy
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
01/08
 
NCT00428194: Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer

Withdrawn
1
0
US
cisplatin, cisplatinum, CDDP, erlotinib hydrochloride, Tarceva(R), radiation therapy, irradiation
Masonic Cancer Center, University of Minnesota
Cervical Cancer
03/08
03/08
NCT00003377: Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix

Completed
1
29
US
cisplatin, paclitaxel, brachytherapy, radiation therapy
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Cancer
07/09
07/09
NCT00005830: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Completed
1
31
US
Doxorubicin Hydrochloride, Cisplatin, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, Irradiation, RT
Gynecologic Oncology Group, National Cancer Institute (NCI)
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer
07/09
 
NCT00005840: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Completed
1
35
US
Paclitaxel, Anzatax, TAX, Cisplatin, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, Irradiation, RT
Gynecologic Oncology Group, National Cancer Institute (NCI)
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer
07/09
 
NCT00287911: Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer

Completed
1
18
US
cisplatin, cisplatinum, CDDP, Platinol AQ, topotecan hydrochloride, Hycamtin, brachytherapy, radiation therapy, radiation
Masonic Cancer Center, University of Minnesota, GlaxoSmithKline
Cervical Cancer
12/09
12/09
NCT00474669: A Phase I Study of Intraperitoneal Hyperthermic Docetaxel

Completed
1
30
US
docetaxel
University of Louisville, James Graham Brown Cancer Center
Ovarian Carcinoma
12/09
12/09
NCT00098995: Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Completed
1
22
Canada, RoW
cisplatin, tirapazamine, brachytherapy, radiation therapy
Peter MacCallum Cancer Centre, Australia, National Cancer Institute (NCI)
Cervical Cancer
01/10
01/10
WAR, NCT00942838: Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity

Withdrawn
1
0
US
Cisplatin, Cisplatin, PLATINOL®-AQ, Whole Abdomen Radiotherapy, radiation therapy
University of Utah
Recurrent Ovarian Carcinoma
04/10
04/10
NCT00967928: Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer

Withdrawn
1
0
US
RAD001, Afinitor, Everolimus, Cisplatin, CDDP, Platinol, External Beam Whole Pelvis Radiation Therapy
Accelerated Community Oncology Research Network, Novartis Pharmaceuticals
Cervical Cancer
12/10
12/10
NCT00448643: Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery

Completed
1
12
US
Vaginal Brachytherapy, Cisplatin, Whole Abdominal Radiation [WAR] Therapy, WAR
University of Miami
Endometrial Cancer
03/11
03/11
NCT00436657: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer

Completed
1
10
US
CHPP of Cisplatin, Platinol®-AQ, Platinol®, CDDP, Abdominal Wash, hyperthermic perfusion, Abdominal Surgery, cytoreductive surgery
M.D. Anderson Cancer Center
Peritoneal Neoplasms, Retroperitoneal Neoplasms, Gastrointestinal Neoplasms, Adenocarcinoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Adrenocortical Carcinoma, Wilms Tumor, Rhabdomyosarcoma, Desmoplastic Small Round Cell Tumor
04/11
04/11
NCT00814086: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Completed
1
23
US
Paclitaxel, Anzatax, TAX, Cisplatin
Gynecologic Oncology Group, National Cancer Institute (NCI)
Chemotherapeutic Agent Toxicity, Endometrial Adenocarcinoma, Fallopian Tube Carcinoma, Gastrointestinal Complication, Malignant Ovarian Mixed Epithelial Tumor, Neurotoxicity Syndrome, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Primary Peritoneal Carcinoma, Stage II Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Undifferentiated Ovarian Carcinoma
07/11
 
NCT00959582: Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)

Completed
1
42
Europe
Comparator: 18-F-FDG PET/CT and Volumetric CT
Merck Sharp & Dohme LLC
Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
10/11
10/11
NCT00054444: Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer

Completed
1
11
US
Topotecan Hydrochloride Liposomes, Brakiva, 3-Dimensional Conformal Radiation Therapy, 3D-CRT, Conformal Therapy, Radiation Conformal Therapy, Cisplatin
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
01/12
 
NCT00702299: Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer

Completed
1
15
US
cisplatin, IP cisplatin, paclitaxel, IP paclitaxel, pemetrexed disodium, Alimta, biologic sample preservation procedure
University of Arizona, National Cancer Institute (NCI)
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
01/12
10/12
NCT00104910: Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Completed
1
64
US
Internal Radiation Therapy, Brachytherapy, Internal Radiation, Internal Radiation Brachytherapy, Radiation Brachytherapy, 3-Dimensional Conformal Radiation Therapy, 3D-CRT, Conformal Therapy, Radiation Conformal Therapy, Cetuximab, Chimeric MoAb C225, Erbitux, IMC-C225, Cisplatin
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
01/13
 
NCT00137358: Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer

Withdrawn
1
0
US
Radiation Therapy, Cisplatin, Amifostine
University of Alabama at Birmingham, MedImmune LLC
Cervical Cancer
 
 
PHOENIX I, NCT01217177: A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer

Completed
1
14
RoW
everolimus, RAD001
Novartis Pharmaceuticals
Locally Advanced Cervical Cancer
04/14
04/14
NCT00550784: Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Completed
1
8
US
filgrastim, cisplatin, cyclophosphamide, melphalan, paclitaxel, topotecan hydrochloride, TdT-mediated dUTP nick end labeling assay, gene expression analysis, immunohistochemistry staining method, pharmacological study, peripheral blood stem cell transplantation
City of Hope Medical Center, National Cancer Institute (NCI)
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
10/14
10/14
NCT01138137: N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer

Withdrawn
1
0
US
Paclitaxel, N-acetylcysteine, NAC, Cisplatin
OHSU Knight Cancer Institute
Ovarian Carcinoma, Stage 3 or 4, Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma
12/14
12/14
NCT01104259: Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Checkmark Data-SABCS
Jan 2012 - Jan 2012: Data-SABCS
Completed
1
50
US
veliparib, ABT-888, cisplatin, CACP, CDDP, CPDD, DDP, vinorelbine tartrate, Eunades, navelbine ditartrate, NVB, VNB, laboratory biomarker analysis, pharmacological study, pharmacological studies
University of Washington, National Cancer Institute (NCI)
Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Hereditary Breast/Ovarian Cancer - BRCA1, Hereditary Breast/Ovarian Cancer - BRCA2, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer
02/15
04/17
NCT01485731: Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

Completed
1
8
US
Nelfinavir, NFV, Cisplatin, Pelvic External Beam Radiation Therapy, PEBRT, Brachytherapy, BT, Pharmacokinetic Sampling, Cervical Biopsy, Pelvic Examination, Pap Smear, Audiogram, Proctoscopy, Cytoscopy, Renal Ultrasound, CT Scan, Whole Body PET/CT Scan
University of Miami
Cervical Cancer
02/15
02/15
NCT02728492: Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Completed
1
51
RoW
Quisinostat, JNJ-26481585, Paclitaxel, Carboplatin, Gemcitabine, Cisplatin
NewVac LLC, Janssen Pharmaceutica N.V., Belgium
Non-small Cell Lung Cancer, Epithelial Ovarian Cancer
12/15
01/16
NCT01665183: Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Completed
1
8
US, RoW
ADI-PEG 20, arginine deiminase formulated with polyethylene glycol
Polaris Group
Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors
02/16
02/16
NCT00575952: Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

Completed
1
27
US
Cisplatin, Doxorubicin Hydrochloride, Filgrastim, Paclitaxel, Pegfilgrastim
Gynecologic Oncology Group, National Cancer Institute (NCI)
Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Squamous Cell Carcinoma, Endometrial Undifferentiated Carcinoma, Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer, Stage IIIC Uterine Corpus Cancer, Stage IVA Uterine Corpus Cancer, Stage IVB Uterine Corpus Cancer
07/16
07/16
PIFA, NCT01719926: Phase I Platinum Based Chemotherapy Plus Indomethacin

Completed
1
13
Europe
Indomethacin
UMC Utrecht
Colorectal Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms
08/17
08/17
NCT01958658: AZD1775, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer

Suspended
1
57
Canada
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiotherapy, External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Internal Radiation Therapy, BRACHYTHERAPY, internal radiation, Internal Radiation Brachytherapy, radiation brachytherapy, Laboratory Biomarker Analysis, Pharmacological Study, Pulsed-Dose Rate Brachytherapy, WEE1 Inhibitor AZD1775, AZD-1775, AZD1775, MK-1775, MK1775
National Cancer Institute (NCI)
Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage IIIA Cervical Cancer, Stage IIIB Cervical Cancer
06/21
 

Download Options